Betta Pharmaceuticals Co., Ltd. is a leading pharmaceutical company based in China, specializing in the development of innovative medicines for various diseases. They offer a wide range of products, including Icotinib hydrochloride for the treatment of non-small-cell lung cancer. With a focus on sustainability and governance, Betta Pharmaceuticals remains committed to high-quality healthcare solutions. Discover how Betta Pharmaceuticals Co., Ltd. in China is revolutionizing the pharmaceutical industry with their innovative medicines and focus on ESG principles. Learn more about their high-risk yet sustainable approach to healthcare solutions.